Liquidia (LQDA)
Liquidia on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
17.3M
Short interest
settlement 2026-10-15
2.0
Days to cover
-1.9 days vs prior
54.1%
Short share of volume
2026-10-28
1,953
Fails to deliver
settlement 2026-09-28
Mon 2 Nov
Next earnings
estimated date
-$25.8M
Insider flow, 90 days
0 buys, 21 sells
As of 2026-10-28.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in LQDA is 17,303,701 shares, up 4,925,725 shares over the last month. Over the last 48 readings it ranged from 9,947,656 shares (30 April 2026) to 22,399,615 shares (15 July 2025). At the reported average volume of 8.7M shares a day that is 2.0 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/lqda" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 17,303,701 | +36.9% | 8,740,139 | 1.98 |
| 2026-09-30 | 12,640,721 | +2.1% | 3,291,757 | 3.84 |
| 2026-09-15 | 12,377,976 | +4.4% | 1,081,412 | 11.45 |
| 2026-08-31 | 11,858,334 | +0.0% | 1,166,814 | 10.16 |
| 2026-08-14 | 11,856,100 | -0.9% | 1,838,095 | 6.45 |
| 2026-07-31 | 11,962,898 | -3.0% | 1,449,810 | 8.25 |
| 2026-07-15 | 12,333,107 | -6.4% | 1,343,837 | 9.18 |
| 2026-06-30 | 13,179,590 | +13.5% | 3,251,301 | 4.05 |
| 2026-06-15 | 11,611,106 | +16.6% | 2,275,741 | 5.10 |
| 2026-05-29 | 9,955,978 | -2.5% | 1,281,423 | 7.77 |
| 2026-05-15 | 10,207,658 | +2.6% | 2,068,293 | 4.94 |
| 2026-04-30 | 9,947,656 | -12.9% | 1,016,024 | 9.79 |
| 2026-04-15 | 11,415,093 | -3.8% | 1,010,838 | 11.29 |
| 2026-03-31 | 11,861,739 | -3.2% | 1,024,935 | 11.57 |
| 2026-03-13 | 12,248,512 | +2.7% | 1,707,804 | 7.17 |
| 2026-02-27 | 11,927,074 | +0.8% | 2,314,372 | 5.15 |
| 2026-02-13 | 11,831,299 | -7.4% | 1,364,483 | 8.67 |
| 2026-01-30 | 12,782,206 | +0.8% | 2,018,686 | 6.33 |
| 2026-01-15 | 12,685,675 | +18.4% | 2,683,572 | 4.73 |
| 2025-12-31 | 10,709,682 | -18.1% | 924,707 | 11.58 |
| 2025-12-15 | 13,078,126 | -7.1% | 1,233,487 | 10.60 |
| 2025-11-28 | 14,080,117 | -12.7% | 2,108,161 | 6.68 |
| 2025-11-14 | 16,124,384 | -8.1% | 2,991,447 | 5.39 |
| 2025-10-31 | 17,552,798 | -1.5% | 2,151,008 | 8.16 |
| 2025-10-15 | 17,817,424 | -3.1% | 2,195,609 | 8.12 |
| 2025-09-30 | 18,386,736 | -0.4% | 3,399,798 | 5.41 |
| 2025-09-15 | 18,467,137 | +7.9% | 2,291,896 | 8.06 |
| 2025-08-29 | 17,116,552 | -6.9% | 2,274,986 | 7.52 |
| 2025-08-15 | 18,387,529 | -12.9% | 3,702,899 | 4.97 |
| 2025-07-31 | 21,110,055 | -5.8% | 2,645,231 | 7.98 |
| 2025-07-15 | 22,399,615 | +4.9% | 2,059,295 | 10.88 |
| 2025-06-30 | 21,352,370 | +9.5% | 2,054,802 | 10.39 |
| 2025-06-13 | 19,503,882 | +17.6% | 3,654,839 | 5.34 |
| 2025-05-30 | 16,589,244 | +22.9% | 2,351,391 | 7.06 |
| 2025-05-15 | 13,499,336 | -0.3% | 1,643,696 | 8.21 |
| 2025-04-30 | 13,536,146 | +2.9% | 999,392 | 13.54 |
| 2025-04-15 | 13,153,619 | +4.9% | 1,471,074 | 8.94 |
| 2025-03-31 | 12,534,841 | +3.8% | 824,001 | 15.21 |
| 2025-03-14 | 12,071,437 | +7.1% | 1,069,286 | 11.29 |
| 2025-02-28 | 11,273,753 | +0.6% | 826,935 | 13.63 |
| 2025-02-14 | 11,208,948 | -0.3% | 788,507 | 14.22 |
| 2025-01-31 | 11,247,585 | +6.6% | 997,811 | 11.27 |
| 2025-01-15 | 10,547,299 | -0.7% | 775,802 | 13.60 |
| 2024-12-31 | 10,623,115 | +1.6% | 707,515 | 15.01 |
| 2024-12-13 | 10,459,896 | -1.0% | 928,886 | 11.26 |
| 2024-11-29 | 10,562,301 | +2.9% | 742,540 | 14.22 |
| 2024-11-15 | 10,262,877 | -0.7% | 846,057 | 12.13 |
| 2024-10-31 | 10,334,276 | -14.8% | 693,402 | 14.90 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 28 October 2026, the short share of LQDA volume is 54.1%, up 6.4 points over the last five sessions. Over the last 30 readings it ranged from 29.4% (5 October 2026) to 75.7% (18 September 2026). The latest reading is in line with the 30-session average of 56.0%, on 927K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-10-28 | 501K | 927K | 54.1% | 3,660 |
| 2026-10-27 | 782K | 1.5M | 53.7% | 195 |
| 2026-10-26 | 987K | 1.8M | 55.2% | 9,279 |
| 2026-10-23 | 870K | 1.5M | 59.5% | 6,883 |
| 2026-10-22 | 720K | 1.3M | 55.5% | 9,000 |
| 2026-10-21 | 822K | 1.7M | 47.7% | 7,200 |
| 2026-10-20 | 789K | 1.4M | 58.1% | 10,353 |
| 2026-10-19 | 746K | 1.3M | 55.8% | 5,219 |
| 2026-10-16 | 986K | 1.6M | 60.7% | 8,014 |
| 2026-10-15 | 2.3M | 3.4M | 66.6% | 27,905 |
| 2026-10-14 | 5.7M | 9.1M | 63.1% | 33,242 |
| 2026-10-13 | 759K | 1.3M | 58.1% | 6,142 |
| 2026-10-12 | 1.2M | 2.0M | 60.9% | 12,393 |
| 2026-10-09 | 766K | 1.5M | 52.0% | 3,054 |
| 2026-10-08 | 1.1M | 2.4M | 48.5% | 337 |
| 2026-10-07 | 1.1M | 3.5M | 31.8% | 7,362 |
| 2026-10-06 | 765K | 2.3M | 32.6% | 704 |
| 2026-10-05 | 1.2M | 4.0M | 29.4% | 3,671 |
| 2026-10-02 | 1.5M | 4.1M | 35.3% | 68,921 |
| 2026-10-01 | 3.8M | 9.8M | 39.0% | 194,353 |
| 2026-09-30 | 6.0M | 10.5M | 57.1% | 566,591 |
| 2026-09-29 | 381K | 581K | 65.6% | 937 |
| 2026-09-28 | 273K | 436K | 62.7% | 3 |
| 2026-09-25 | 254K | 407K | 62.4% | 2,608 |
| 2026-09-24 | 260K | 428K | 60.8% | 61 |
| 2026-09-23 | 208K | 291K | 71.6% | 2,341 |
| 2026-09-22 | 204K | 285K | 71.4% | 29 |
| 2026-09-21 | 207K | 314K | 65.9% | 3,197 |
| 2026-09-18 | 253K | 334K | 75.7% | 1,700 |
| 2026-09-17 | 208K | 301K | 69.3% | 1,903 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 28 September 2026, the fails-to-deliver balance in LQDA is 1,953 shares, up 433 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (10 June 2026) to 64,338 shares (9 June 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-28 | 1,953 | $68.43 | $134K |
| 2026-09-23 | 1,520 | $68.64 | $104K |
| 2026-09-17 | 1,213 | $68.45 | $83K |
| 2026-09-16 | 40 | $65.72 | $3K |
| 2026-09-10 | 7 | $69.12 | $484 |
| 2026-09-03 | 29,000 | $69.68 | $2.0M |
| 2026-08-31 | 4,662 | $67.69 | $316K |
| 2026-08-24 | 7,141 | $68.62 | $490K |
| 2026-08-19 | 22 | $74.33 | $2K |
| 2026-08-12 | 57 | $88.05 | $5K |
| 2026-08-11 | 1,639 | $91.03 | $149K |
| 2026-08-10 | 1,200 | $90.22 | $108K |
| 2026-08-07 | 54 | $89.42 | $5K |
| 2026-08-04 | 11,951 | $83.85 | $1.0M |
| 2026-08-03 | 33 | $84.11 | $3K |
| 2026-07-30 | 2,313 | $86.82 | $201K |
| 2026-07-20 | 6,120 | $79.94 | $489K |
| 2026-07-17 | 92 | $75.27 | $7K |
| 2026-07-07 | 98 | $79.21 | $8K |
| 2026-07-06 | 332 | $78.93 | $26K |
| 2026-06-30 | 43 | $75.12 | $3K |
| 2026-06-29 | 10,882 | $78.17 | $851K |
| 2026-06-25 | 35,657 | $75.54 | $2.7M |
| 2026-06-24 | 116 | $74.04 | $9K |
| 2026-06-23 | 3,000 | $75.49 | $226K |
| 2026-06-22 | 11 | $71.07 | $782 |
| 2026-06-18 | 1 | $68.65 | $69 |
| 2026-06-10 | 1 | $64.01 | $64 |
| 2026-06-09 | 64,338 | $63.90 | $4.1M |
| 2026-06-08 | 1,327 | $61.85 | $82K |
Insider trades
SEC Form 4, newest first. JSONInsiders at LQDA reported 21 open-market sells worth $25.8M in the last 90 days and no open-market buys. Latest filing: Boyle Dana (Chief Accounting Officer) on 2026-10-26.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-10-26 | Boyle Dana | Chief Accounting Officer | Sell | 2K | $43.19 | $68K | 164K |
| 2026-10-26 | Adair Jason | Chief Business Officer | Sell | 688 | $43.19 | $30K | 177K |
| 2026-10-12 | JEFFS ROGER | Chief Executive Officer | Sell | 33K | $28.48 | $933K | 1.1M |
| 2026-10-12 | Kaseta Michael | CFO and COO | Sell | 19K | $28.48 | $539K | 340K |
| 2026-10-12 | Khindri Sanjeev | Chief Development Officer | Sell | 1K | $28.48 | $31K | 65K |
| 2026-10-12 | Krepp Sarah | Chief Human Resource Officer | Sell | 5K | $28.48 | $149K | 115K |
| 2026-10-12 | Moomaw Scott | Chief Commercial Officer | Sell | 9K | $28.48 | $252K | 181K |
| 2026-10-12 | Saggar Rajeev | Chief Medical Officer | Sell | 9K | $28.48 | $263K | 126K |
| 2026-10-12 | Schundler Russell | General Counsel | Sell | 14K | $28.48 | $390K | 603K |
| 2026-10-12 | Adair Jason | Chief Business Officer | Sell | 7K | $28.48 | $208K | 178K |
| 2026-10-12 | Boyle Dana | Chief Accounting Officer | Sell | 6K | $28.48 | $168K | 166K |
| 2026-10-09 | JEFFS ROGER | Chief Executive Officer | Exercise or conversion | 14K | price not stated in the filing | not stated | 1.2M |
| 2026-10-09 | JEFFS ROGER | Chief Executive Officer | Exercise or conversion | 14K | price not stated in the filing | not stated | 1.1M |
| 2026-10-09 | Kaseta Michael | CFO and COO | Exercise or conversion | 7K | price not stated in the filing | not stated | 359K |
| 2026-10-09 | Kaseta Michael | CFO and COO | Exercise or conversion | 6K | price not stated in the filing | not stated | 352K |
| 2026-10-09 | Krepp Sarah | Chief Human Resource Officer | Exercise or conversion | 3K | price not stated in the filing | not stated | 120K |
| 2026-10-09 | Moomaw Scott | Chief Commercial Officer | Exercise or conversion | 4K | price not stated in the filing | not stated | 190K |
| 2026-10-09 | Moomaw Scott | Chief Commercial Officer | Exercise or conversion | 3K | price not stated in the filing | not stated | 186K |
| 2026-10-09 | Saggar Rajeev | Chief Medical Officer | Exercise or conversion | 4K | price not stated in the filing | not stated | 136K |
| 2026-10-09 | Saggar Rajeev | Chief Medical Officer | Exercise or conversion | 4K | price not stated in the filing | not stated | 131K |
| 2026-10-09 | Schundler Russell | General Counsel | Exercise or conversion | 6K | price not stated in the filing | not stated | 617K |
| 2026-10-09 | Schundler Russell | General Counsel | Exercise or conversion | 4K | price not stated in the filing | not stated | 610K |
| 2026-10-09 | Adair Jason | Chief Business Officer | Exercise or conversion | 4K | price not stated in the filing | not stated | 185K |
| 2026-10-09 | Adair Jason | Chief Business Officer | Exercise or conversion | 2K | price not stated in the filing | not stated | 181K |
| 2026-10-09 | Adair Jason | Chief Business Officer | Exercise or conversion | 4K | price not stated in the filing | not stated | 179K |
| 2026-10-09 | Boyle Dana | Chief Accounting Officer | Exercise or conversion | 3K | price not stated in the filing | not stated | 172K |
| 2026-10-05 | Bloch Stephen M | Director | Sell | 235K | $27.13 | $6.4M | 0 |
| 2026-09-14 | SINGH RAMAN | Director | Sell | 8K | $66.16 | $560K | 45K |
| 2026-09-14 | SINGH RAMAN | Director | Exercise or conversion | 8K | $9.31 | $79K | 53K |
| 2026-09-11 | SINGH RAMAN | Director | Sell | 9K | $68.62 | $619K | 45K |
| 2026-09-11 | SINGH RAMAN | Director | Exercise or conversion | 8K | $9.31 | $79K | 54K |
| 2026-09-11 | SINGH RAMAN | Director | Exercise or conversion | 556 | $8.63 | $5K | 45K |
| 2026-09-01 | Krepp Sarah | Chief Human Resource Officer | Sell | 274 | $67.76 | $19K | 117K |
| 2026-08-21 | Adair Jason | Chief Business Officer | Sell | 42K | $69.09 | $2.9M | 175K |
| 2026-08-21 | Adair Jason | Chief Business Officer | Sell | 32K | $69.09 | $2.2M | 216K |
| 2026-08-21 | Adair Jason | Chief Business Officer | Exercise or conversion | 238 | $14.20 | $3K | 248K |
| 2026-08-21 | Adair Jason | Chief Business Officer | Exercise or conversion | 11K | $14.20 | $153K | 248K |
| 2026-08-21 | Adair Jason | Chief Business Officer | Exercise or conversion | 12K | $9.31 | $110K | 237K |
| 2026-08-21 | Adair Jason | Chief Business Officer | Exercise or conversion | 9K | $9.31 | $84K | 225K |
| 2026-08-20 | Rielly-Gauvin Katherine | Director | Sell | 18K | $72.23 | $1.3M | 45K |
| 2026-08-20 | Rielly-Gauvin Katherine | Director | Exercise or conversion | 7K | $2.59 | $17K | 63K |
| 2026-08-20 | Rielly-Gauvin Katherine | Director | Exercise or conversion | 12K | $2.51 | $29K | 56K |
| 2026-08-19 | Rielly-Gauvin Katherine | Director | Sell | 37K | $74.99 | $2.8M | 45K |
| 2026-08-19 | Rielly-Gauvin Katherine | Director | Exercise or conversion | 13K | $2.59 | $35K | 81K |
| 2026-08-19 | Rielly-Gauvin Katherine | Director | Exercise or conversion | 23K | $2.51 | $59K | 68K |
| 2026-08-19 | Saggar Rajeev | Chief Medical Officer | Sell | 50K | $74.06 | $3.7M | 142K |
| 2026-08-19 | Saggar Rajeev | Chief Medical Officer | Exercise or conversion | 50K | $3.73 | $187K | 192K |
| 2026-08-17 | Saggar Rajeev | Chief Medical Officer | Sell | 30K | $76.84 | $2.3M | 142K |
| 2026-07-27 | Boyle Dana | Chief Accounting Officer | Sell | 2K | $87.53 | $140K | 168K |
| 2026-07-27 | Adair Jason | Chief Business Officer | Sell | 688 | $87.53 | $60K | 216K |
| 2026-07-23 | Bloch Stephen M | Director | Sell | 4K | $90.71 | $327K | 501K |
| 2026-07-23 | Bloch Stephen M | Director | Sell | 96K | $89.44 | $8.6M | 505K |
| 2026-07-22 | Bloch Stephen M | Director | Sell | 15K | $89.24 | $1.3M | 601K |
| 2026-07-22 | Bloch Stephen M | Director | Sell | 48K | $88.65 | $4.3M | 616K |
| 2026-07-22 | Bloch Stephen M | Director | Sell | 37K | $87.70 | $3.3M | 664K |
| 2026-07-21 | Bloch Stephen M | Director | Sell | 556 | $80.66 | $45K | 701K |
| 2026-07-21 | Bloch Stephen M | Director | Sell | 74K | $79.98 | $6.0M | 702K |
| 2026-07-20 | Bloch Stephen M | Director | Sell | 4K | $79.55 | $286K | 776K |
| 2026-07-13 | Schundler Russell | General Counsel | Sell | 14K | $71.52 | $979K | 606K |
| 2026-07-13 | Schundler Russell | General Counsel | Sell | 1K | $71.39 | $75K | 620K |
| 2026-07-13 | Saggar Rajeev | Chief Medical Officer | Sell | 9K | $71.52 | $660K | 172K |
| 2026-07-13 | Saggar Rajeev | Chief Medical Officer | Sell | 703 | $71.39 | $50K | 181K |
| 2026-07-13 | Moomaw Scott | Chief Commercial Officer | Sell | 9K | $71.52 | $634K | 182K |
| 2026-07-13 | Moomaw Scott | Chief Commercial Officer | Sell | 675 | $71.39 | $48K | 191K |
| 2026-07-13 | Krepp Sarah | Chief Human Resource Officer | Sell | 7K | $71.52 | $523K | 117K |
| 2026-07-13 | Krepp Sarah | Chief Human Resource Officer | Sell | 558 | $71.39 | $40K | 124K |
| 2026-07-13 | Khindri Sanjeev | Chief Development Officer | Sell | 1K | $71.52 | $79K | 66K |
| 2026-07-13 | Khindri Sanjeev | Chief Development Officer | Sell | 84 | $71.39 | $6K | 67K |
| 2026-07-13 | Kaseta Michael | CFO and COO | Sell | 19K | $71.52 | $1.4M | 346K |
| 2026-07-13 | Kaseta Michael | CFO and COO | Sell | 1K | $71.39 | $104K | 365K |
| 2026-07-13 | JEFFS ROGER | Chief Executive Officer | Sell | 33K | $71.52 | $2.3M | 1.1M |
| 2026-07-13 | JEFFS ROGER | Chief Executive Officer | Sell | 3K | $71.39 | $179K | 1.2M |
| 2026-07-13 | Boyle Dana | Chief Accounting Officer | Sell | 8K | $71.52 | $598K | 170K |
| 2026-07-13 | Boyle Dana | Chief Accounting Officer | Sell | 641 | $71.39 | $46K | 178K |
| 2026-07-13 | Adair Jason | Chief Business Officer | Sell | 7K | $71.52 | $522K | 217K |
| 2026-07-13 | Adair Jason | Chief Business Officer | Sell | 562 | $71.39 | $40K | 224K |
| 2026-07-10 | Schundler Russell | General Counsel | Exercise or conversion | 6K | price not stated in the filing | not stated | 621K |
| 2026-07-10 | Schundler Russell | General Counsel | Exercise or conversion | 4K | price not stated in the filing | not stated | 614K |
| 2026-07-10 | Saggar Rajeev | Chief Medical Officer | Exercise or conversion | 4K | price not stated in the filing | not stated | 182K |
| 2026-07-10 | Saggar Rajeev | Chief Medical Officer | Exercise or conversion | 4K | price not stated in the filing | not stated | 177K |
| 2026-07-10 | Moomaw Scott | Chief Commercial Officer | Exercise or conversion | 4K | price not stated in the filing | not stated | 192K |
| 2026-07-10 | Moomaw Scott | Chief Commercial Officer | Exercise or conversion | 3K | price not stated in the filing | not stated | 188K |
| 2026-07-10 | Krepp Sarah | Chief Human Resource Officer | Exercise or conversion | 3K | price not stated in the filing | not stated | 125K |
| 2026-07-10 | Kaseta Michael | CFO and COO | Exercise or conversion | 7K | price not stated in the filing | not stated | 366K |
| 2026-07-10 | Kaseta Michael | CFO and COO | Exercise or conversion | 6K | price not stated in the filing | not stated | 359K |
| 2026-07-10 | JEFFS ROGER | Chief Executive Officer | Exercise or conversion | 14K | price not stated in the filing | not stated | 1.2M |
| 2026-07-10 | JEFFS ROGER | Chief Executive Officer | Exercise or conversion | 14K | price not stated in the filing | not stated | 1.2M |
| 2026-07-10 | Boyle Dana | Chief Accounting Officer | Exercise or conversion | 3K | price not stated in the filing | not stated | 179K |
| 2026-07-10 | Adair Jason | Chief Business Officer | Exercise or conversion | 4K | price not stated in the filing | not stated | 225K |
| 2026-07-10 | Adair Jason | Chief Business Officer | Exercise or conversion | 2K | price not stated in the filing | not stated | 221K |
| 2026-07-10 | Adair Jason | Chief Business Officer | Exercise or conversion | 4K | price not stated in the filing | not stated | 219K |
| 2026-07-07 | Bloch Stephen M | Director | Sell | 27K | $81.31 | $2.2M | 780K |
| 2026-07-07 | Bloch Stephen M | Director | Sell | 23K | $80.48 | $1.8M | 807K |
| 2026-07-06 | Bloch Stephen M | Director | Sell | 25K | $80.17 | $2.0M | 830K |
| 2026-07-01 | Bloch Stephen M | Director | Sell | 853 | $80.05 | $68K | 855K |
| 2026-07-01 | Bloch Stephen M | Director | Sell | 24K | $79.45 | $1.9M | 856K |
| 2026-06-22 | Bloch Stephen M | Director | Sell | 31K | $76.18 | $2.3M | 880K |
| 2026-06-22 | Bloch Stephen M | Director | Sell | 70K | $75.54 | $5.3M | 911K |
| 2026-06-16 | Manning Paul B | Director | Grant | 6K | $0.00 | $0 | 475K |
| 2026-06-16 | Rielly-Gauvin Katherine | Director | Grant | 6K | $0.00 | $0 | 45K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON36 Form 144 notices on file for LQDA worth $137.2M at the prices reported; 6 in the last 90 days worth $16.5M. Latest: RAMANDEEP SINGH filed on 2026-09-14 to sell 8,468 shares ($560K) from 2026-09-14.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-14 | RAMANDEEP SINGHDirector | 8K | $560K | 0.009% | 2026-09-14 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-11 | RAMANDEEP SINGHDirector | 9K | $619K | 0.010% | 2026-09-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-21 | JASON ADAIROfficer | 74K | $5.2M | 0.082% | 2026-08-21 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-19 | Katherine T. Rielly-GauvinDirector | 55K | $4.1M | 0.062% | 2026-08-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-19 | RAJEEV SAGGAROfficer | 50K | $3.7M | 0.056% | 2026-08-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-17 | RAJEEV SAGGAROfficer | 30K | $2.3M | 0.033% | 2026-08-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-11 | SARAH KREPPOfficer | 25K | $1.6M | 0.028% | 2026-06-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-10 | Canaan VIII LPDirector | 200K | $13.0M | 0.227% | 2026-06-10 | UBS Financial Services Inc |
| 2026-06-08 | Canaan VIII LPDirector | 200K | $12.8M | 0.227% | 2026-06-08 | UBS Financial Services Inc |
| 2026-06-04 | Paul B ManningDirector | 200K | $11.1M | 0.225% | 2026-06-04 | Fidelity Brokerage Services LLC |
| 2026-06-04 | Canaan VIII LPDirector | 200K | $13.0M | 0.227% | 2026-06-04 | UBS Financial Services Inc |
| 2026-06-01 | KIRSCH ARTHUR SDirector | 30K | $1.8M | 0.034% | 2026-06-01 | Fidelity Brokerage Services LLC |
| 2026-05-21 | RAMANDEEP SINGHDirector | 29K | $1.8M | 0.033% | 2026-05-21 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-20 | SERENDIPITY BIOPHARMA LLCDirector, Officer | 106K | $6.4M | 0.120% | 2026-05-20 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-14 | SERENDIPITY BIOPHARMA LLCDirector, Officer | 100K | $5.8M | 0.112% | 2026-05-14 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-11 | Canaan VIII LPDirector | 319K | $15.9M | 0.362% | 2026-05-11 | UBS Financial Services Inc |
| 2026-05-08 | SERENDIPITY BIOPHARMA LLCDirector, Officer | 100K | $4.2M | 0.113% | 2026-05-08 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-07 | SERENDIPITY BIOPHARMA LLCDirector, Officer | 25K | $1.1M | 0.028% | 2026-05-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-17 | SERENDIPITY BIOPHARMA LLCDirector, Officer | 69K | $2.8M | 0.078% | 2026-04-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-16 | SERENDIPITY BIOPHARMA LLCDirector, Officer | 25K | $1.0M | 0.028% | 2026-04-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-15 | MICHAEL KASETAOfficer | 139K | $5.4M | 0.158% | 2026-04-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-15 | SERENDIPITY BIOPHARMA LLCDirector, Officer | 25K | $957K | 0.028% | 2026-04-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-14 | MICHAEL KASETAOfficer | 3K | $117K | 0.003% | 2026-04-14 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-10 | MICHAEL KASETAOfficer | 24K | $960K | 0.027% | 2026-04-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-10 | SERENDIPITY BIOPHARMA LLCDirector, Officer | 25K | $1.0M | 0.028% | 2026-04-10 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-09 | MICHAEL KASETAOfficer | 134K | $5.1M | 0.152% | 2026-04-09 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-09 | SERENDIPITY BIOPHARMA LLCDirector, Officer | 25K | $955K | 0.028% | 2026-04-09 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-27 | Canaan VIII LPBoard Member | 63K | $2.1M | 0.071% | 2026-03-27 | UBS Financial Services Inc |
| 2026-03-13 | RAMANDEEP SINGHDirector | 40K | $1.5M | 0.046% | 2026-03-13 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-13 | Rajeev SaggarOfficer | 35K | $1.3M | 0.040% | 2026-03-13 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-13 | SARAH T KREPPOfficer | 16K | $618K | 0.018% | 2026-03-13 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-09 | SCOTT MOOMAWOfficer | 100K | $3.6M | 0.113% | 2026-03-09 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-18 | JASON ADAIROfficer | 36K | $1.0M | 0.041% | 2025-11-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-07 | Dana BoyleOfficer | 29K | $728K | 0.033% | 2025-11-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-05 | Rajeev SaggarOfficer | 71K | $1.9M | 0.082% | 2025-11-05 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-09-15 | RAMANDEEP SINGHDirector | 46K | $1.2M | 0.053% | 2025-09-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON18 holders report 5% or more of LQDA in their latest filing, all on Schedule 13G (passive). The largest reported stake is BlackRock, Inc. at 11.9% of the class (10,551,901 shares), filed 2026-07-08 for an event on 2026-06-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-14 | 13G/Ano. 5 | Paul B Manningindividual | 4.9M | 6.5% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 5 | BKB Growth Investments, LLCother entity | 716K | 0.8% | 2026-06-30 |
| 2026-08-14 | 13G/Ano. 5 | PD Joint Holdings, LLC Series 2016-Aother entity | 198K | 0.2% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Capital Management, L.L.C.investment adviser, other entity | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Dreyfuss, Philip D.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Dunn Hannah E.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Gehani, Varun N.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Giauque, Nicolasparent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Husen, Avner A.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Kim, David T.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Linn, Michael G.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Luo Patrick (Cheng)parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Roberts, Jr., Thomas G.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Saito Edric C.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Short Daniel S.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Spokes, Andrew J. M.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Warren, John R.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Wehrly, Mark C.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Dapice Joshua J.parent holding company, individual | 8.4M | 9.4% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Capital Institutional Partners II, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Four Crossings Institutional Partners V, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Capital Offshore Investors II, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Capital (AM) Investors, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Capital F5 Master I, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Healthcare Partners Master, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Partners, L.L.C.other entity | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Institutional (GP) V, L.L.C.other entity | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon F5 (GP), L.L.C.other entity | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Healthcare Partners (GP), L.L.C.other entity | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Capital Institutional Partners, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Capital Partners, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-08-04 | 13G/Ano. 3 | Farallon Capital Institutional Partners III, L.P.partnership | 0 | 0.0% | 2026-06-30 |
| 2026-07-08 | 13G/Ano. 1 | BlackRock, Inc.parent holding company | 10.6M | 11.9% | 2026-06-30 |
| 2026-02-09 | 13G/Ano. 2 | Fried, Richard Bindividual | 0 | 0.0% | 2025-12-31 |
| 2026-02-09 | 13G/Ano. 2 | Patel, Rajiv A.individual | 0 | 0.0% | 2025-12-31 |
| 2026-02-09 | 13G/Ano. 2 | Seybold, Williamindividual | 0 | 0.0% | 2025-12-31 |
13F holders
Tracked managers holding LQDA at their latest 13F. JSON4 of the 30 tracked managers held LQDA at their latest 13F, $147.7M in total at quarter-end prices. D. E. Shaw & Co. is the largest at $101.1M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| D. E. Shaw & Co. | 2026-06-30 | 1.3M | $101.1M | 0.05% | +395K |
| Two Sigma Investments | 2026-06-30 | 267K | $21.3M | 0.02% | -296K |
| Renaissance Technologies | 2026-06-30 | 232K | $18.5M | 0.03% | +224K |
| AQR Capital Management | 2026-06-30 | 85K | $6.8M | 0.00% | +36K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Liquidia reported revenue of $171.7M, up 1842.7% from the same quarter a year earlier, and net income of $74.7M (0.74 diluted EPS). In FY 2025 it generated -$35.7M of operating cash flow.
- Cash
- $284.2M
- Equity
- $195.1M
- Total assets
- $521.9M
- Shares outstanding
- 89,508,891
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $171.7M | $74.7M | 43.5% | 0.74 |
| Q1 FY 2026 | 2026-03-31 | $132.9M | $52.9M | 39.8% | 0.52 |
| Q4 FY 2025derived | 2025-12-31 | $92.0M | $14.6M | 15.8% | n/a |
| Q3 FY 2025 | 2025-09-30 | $54.3M | -$3.5M | -6.5% | -0.04 |
| Q2 FY 2025 | 2025-06-30 | $8.8M | -$41.6M | -470.5% | -0.49 |
| Q1 FY 2025 | 2025-03-31 | $3.1M | -$38.4M | -1229.7% | -0.45 |
| Q4 FY 2024 | 2024-12-31 | $2.9M | -$38.5M | -1320.2% | -0.45 |
| Q3 FY 2024 | 2024-09-30 | $4.4M | -$31.0M | -697.6% | -0.40 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $158.3M | -$68.9M | -$35.7M | $4.3M | n/a | n/a |
| FY 2024 | 2024-12-31 | $14.0M | -$128.3M | -$93.4M | $4.9M | n/a | n/a |
| FY 2023 | 2023-12-31 | $17.5M | -$78.5M | -$41.6M | $1.3M | n/a | n/a |
| FY 2022 | 2022-12-31 | $15.9M | -$41.0M | -$28.6M | $592K | n/a | n/a |
| FY 2021 | 2021-12-31 | $12.9M | -$34.6M | -$34.0M | $107K | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-29 from the cover page.
What this page is
Liquidia in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Liquidia (LQDA), SEC CIK 1819576, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-10-28.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-28.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-09-14.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-14.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-12.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-10-26.JSON and CSV
- Company record
- EDGAR filing index for CIK 1819576Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
- BNOUnited States Brent Oil Fund
- BNSBank of Nova Scotia
- BNYBank of New York Mellon
- BRBroadridge Financial Solutions
- BRK-BBerkshire Hathaway
- BRKRBruker
- BROBrown & Brown
- BROSDutch Bros
- BSXBoston Scientific
- BTGB2Gold
- BTIBritish American Tobacco
- BTSGBrightSpring Health Services
- BUDAnheuser-Busch InBev
- BULLWebull
- BURLBurlington Stores
- BWABorgWarner
Datasets
Frequently Asked Questions
How much of LQDA is sold short?
17,303,701 shares were held short at the 2026-10-15 settlement, 2.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is LQDA's daily short volume?
On 2026-10-28, 501,225 of the 926,518 LQDA shares reported to FINRA were sold short, 54.1% of the day's reported volume. Short volume is a flow for one day, not a position.
Does LQDA have fails to deliver?
The SEC's latest file shows 1,953 LQDA shares failed to deliver at settlement 2026-09-28. Fails are reported per settlement date and published twice a month with a lag.
Are LQDA insiders buying or selling?
Insiders at LQDA reported 21 open-market sells worth $25.8M in the last 90 days and no open-market buys. Latest filing: Boyle Dana (Chief Accounting Officer) on 2026-10-26.
Have LQDA insiders filed to sell?
36 Form 144 notices on file for LQDA worth $137.2M at the prices reported; 6 in the last 90 days worth $16.5M. Latest: RAMANDEEP SINGH filed on 2026-09-14 to sell 8,468 shares ($560K) from 2026-09-14.
Who owns 5% or more of LQDA?
18 holders report 5% or more of LQDA in their latest filing, all on Schedule 13G (passive). The largest reported stake is BlackRock, Inc. at 11.9% of the class (10,551,901 shares), filed 2026-07-08 for an event on 2026-06-30.
What did LQDA report last quarter?
In Q2 FY 2026 (quarter ended 2026-06-30) Liquidia reported revenue of $171.7M, up 1842.7% from the same quarter a year earlier, and net income of $74.7M (0.74 diluted EPS). In FY 2025 it generated -$35.7M of operating cash flow.
Which tracked 13F managers own LQDA?
4 of the 30 tracked 13F managers held LQDA shares at their latest filing, $147.7M in all. The largest: D. E. Shaw & Co. (1.3M shares, $101.1M), Two Sigma Investments (267K shares, $21.3M), Renaissance Technologies (232K shares, $18.5M), Cliff Asness's AQR Capital Management (85K shares, $6.8M).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.